茵栀黄口服液联合思密达治疗新生儿母乳性黄疸的临床疗效分析.docVIP

茵栀黄口服液联合思密达新生儿母乳性黄疸临床疗效分析 口服液联合思密达新生母乳性黄疸中的效果。到的黄疸新生儿中选取作为本的研究。这些病例时间的顺序均分为治疗组和两个实验组。采用口服液联合思密达对患儿进行治疗，则采用常规进行治疗对两组患儿住院时间血清进行并根据的疗效标准对患儿进行评定，观察两组的总有效率为%，高于%）胆红素下降值为mol/L，也远远高于对照组27.65±8.73μmol/L）住院时间也，具有统计学意义（）口服液联合思密达新生儿母乳性黄疸安全的临床效果，有效的血清胆红素水平黄疸，相比疗效，在临床大力推广应用。；母乳性黄疸；口服液；疗效分析The curative effect analysis of yinzhihuang?oral liquid combined with smecta in?treatment of 40 cases of breast?milk jaundice?of?newborn [Abstract]Objective To research the curative effect analysis of yinzhihuang?oral liquid combined with smecta in?treatment of 40 cases of breast?milk jaundice?of?newborn. Methods From July 2012?to?March 2014, 80 cases with breast milk jaundice were selected in our hospital as the research object. According to the?sequence of?admission?time, these?cases were?divided into?the treatment group?and the control group, each?group?of?each?40?cases. The treatment group used?yinzhihuang?oral liquid combined with smecta in the treatment. The control group was?treated by?conventional?means. Analyzed and compared the two?groups of children with the time of jaundice, the hospitalization time and?serum total bilirubin?level changes. According to the?standard of curative effect, judged and counted two groups of children with?treatment,?observed the clinical curative effect?of the two groups of children. Results The total effective rate of the treatment group?was 97.5%,?significantly higher than the control group?(92.5%). Serum total bilirubin?decreased?daily?value of?treatment group was 38.22±13.79 mol/L, significantly?higher than the control group?(27.65±8.73 mol/L). The treatment group?of the jaundice subsided?time was 4.12±2.65d,?significantly faster than?the control group（d）,?with significant difference?(P0.05). Conclusion In the?treatment of breast?milk jaundice?of?newborn the clinical effect?of yinzhihuang?oral liquid?combined with smecta?has great?safety. Can effectively reduce the?serum bilirubin?level in children, shorten the?time of?jaundice. Compared?with the tradit